With thousands of research abstracts and posters being presented at ACR Convergence 2024, Nov. 14–19, at the Walter E. Washington Convention Center in Washington, D.C., figuring out which research is important today, which could prove important in the future, what has the potential to affect clinical care or prove the basis for future research is more than most attendees have time to tackle. That’s where we come in.
The Rheumatologist asked Jeffrey Curtis, MD, MS, MPH, to sort through the research and give us his take on the most important research on rheumatoid arthritis (RA) being presented at the annual meeting. A researcher, academician and an expert on RA, Dr. Curtis is the perfect person to review the new research.
He is the Marguerite Jones Harbert-Gene Ball Endowed professor of medicine, Division of Clinical Immunology & Rheumatology, University of Alabama at Birmingham. A rheumatologist and epidemiologist, Dr. Curtis has research interests in rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis and osteoporosis, as well as methodologic interests in real-world evidence, causal inference, machine learning and artificial intelligence. You can review his full academic profile here.
Dr. Curtis will identify the important research, summarize the abstracts and comment on why each is important. He will address the relevance for clinicians and the potential impact on future research.
Check back after the conference for his full report.